The protective effect of nesfatin-1 against renal ischemia–reperfusion injury in rats

References

• Grace PA. Ischemia–reperfusion injury. Br J Surg. 1994;81:637–647
   PubMed Web of Science ®Google Scholar
• Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, Ward PA. Ischemia/reperfusion injury. J Surg Res. 2002;105:248–258
   PubMed Web of Science ®Google Scholar
• Dorai T, Fishman AI, Ding C, Batinic-Haberle I, Goldfarb DS, Grasso M. Amelioration of renal ischemia–reperfusion injury with a novel protective cocktail. J Urol. 2011;186:2448–2454
   PubMed Web of Science ®Google Scholar
• Weight SC, Bell PR, Nicholson ML. Renal ischemia–reperfusion injury. Br J Surg. 1996;83:162–170
   PubMed Web of Science ®Google Scholar
• Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 1984;74:1156–1164
   PubMed Web of Science ®Google Scholar
• Meldrum DR, Ayala A, Wang P, Ertel W, Chaudry IH. Association between decreased splenic ATP levels and immunodepression: Amelioration with ATP-MgCl2. Am J Physiol. 1991;261:R351–R357
   Google Scholar
• Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 1997;51:1463–1468
   PubMed Web of Science ®Google Scholar
• Wang P, Ba ZF, Meldrum DR, Chaudry IH. Diltiazem restores cardiac output and improves renal function after hemorrhagic shock and crystalloid resuscitation. Am J Physiol. 1992;262:H1435–H1440
   Google Scholar
• Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation. 1989;80:1115–1127
   PubMed Web of Science ®Google Scholar
• Oh IS, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443:709–712
   PubMed Web of Science ®Google Scholar
• Cowley MA, Grove KL. To be or NUCB2, is nesfatin the answer? Cell Metab. 2006;4:421–422
   PubMed Web of Science ®Google Scholar
• Colmers WF. Less fat with nesfatin. Trends Endocrinol Metab. 2007;18:131–132
   PubMed Web of Science ®Google Scholar
• Merali Z, Cayer C, Kent P, Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology (Berl). 2008;201:115–123
   PubMed Web of Science ®Google Scholar
• Bonnet MS, Pecchi E, Trouslard J, Jean A, Dallaporta M, Troadec JD. Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus. J Neuroinflamm. 2009;6:27–35
   PubMed Web of Science ®Google Scholar
• Pan W, Hsuchou H, Kastin AJ. Nesfatin-1 crosses the blood–brain barrier without saturation. Peptides. 2007;28:2223–2228
   PubMed Web of Science ®Google Scholar
• Price TO, Samson WK, Niehoff ML, Banks WA. Permeability of the blood–brain barrier to a novel satiety molecule nesfatin-1. Peptides. 2007;28:2372–2381
   PubMed Web of Science ®Google Scholar
• Kolgazi M, Cantali-Ozturk C, Deniz R, et al. Nesfatin-1 alleviates gastric damage via direct antioxidant mechanisms. J Surg Res. 2015;193:111–118
   PubMed Web of Science ®Google Scholar
• Ozsavci D, Ersahin M, Sener A, et al. The novel function of nesfatin-1 as an anti-inflammatory and antiapoptotic peptide in subarachnoid hemorrhage-induced oxidative brain damage in rats. Neurosurgery. 2011;68:1699–1708; discussion 1708
   PubMed Web of Science ®Google Scholar
• Angelone T, Filice E, Pasqua T, et al. Nesfatin-1 as a novel cardiac peptide: Identification, functional characterization, and protection against ischemia/reperfusion injury. Cell Mol Life Sci. 2013;70:495–509
   PubMed Web of Science ®Google Scholar
• Liu X, Chen H, Zhan B, et al. Attenuation of reperfusion injury by renal ischemic postconditioning: The role of NO. Biochem Biophys Res Commun. 2007;359:628–634
   PubMed Web of Science ®Google Scholar
• Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497–500
   PubMed Web of Science ®Google Scholar
• Ji HJ, Hu JF, Wang YH, Chen XY, Zhou R, Chen NH. Osthole improves chronic cerebral hypoperfusion induced cognitive deficits and neuronal damage in hippocampus. Eur J Pharmacol. 2010;636:96–101
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358
   PubMed Web of Science ®Google Scholar
• Chatterjee PK, Zacharowski K, Cuzzocrea S, et al. Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury. Kidney Int. 2002;62:1249–1263
   PubMed Web of Science ®Google Scholar
• Bonegio R, Lieberthal W. Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens. 2002;11:301–308
   PubMed Web of Science ®Google Scholar
• Chen H, Xing B, Liu X, et al. Ischemic postconditioning inhibits apoptosis after renal ischemia/reperfusion injury in rat. Transplant Int. 2008;21:364–371
   PubMed Web of Science ®Google Scholar
• Qiao X, Li RS, Li H, et al. Intermedin protects against renal ischemia-reperfusion injury by inhibition of oxidative stress. Am J Physiol Renal Physiol. 2013;304:F112–F119
   PubMed Web of Science ®Google Scholar
• Koc M, Kumral ZN, Ozkan N, et al. Obestatin improves ischemia/reperfusion-induced renal injury in rats via its antioxidant and anti-apoptotic effects: Role of the nitric oxide. Peptides. 2014;60C:23–31
   Web of Science ®Google Scholar
• Aragno M, Cutrin JC, Mastrocola R, et al. Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: Attenuation by dehydroepiandrosterone. Kidney Int. 2003;64:836–843
   PubMed Web of Science ®Google Scholar
• Singh D, Chopra K. The effect of naringin, a bioflavonoid on ischemia–reperfusion induced renal injury in rats. Pharmacol Res. 2004;50:187–193
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Koo DD, Davies DR, et al. Lecithinized superoxide dismutase reduces cold ischemia-induced chronic allograft dysfunction. Kidney Int. 2002;61:1160–1169
   PubMed Web of Science ®Google Scholar
• Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 2003;14:2199–2210
   PubMed Web of Science ®Google Scholar
• Chatterjee PK, Todorovic Z, Sivarajah A, et al. Inhibitors of calpain activation (PD150606 and E-64) and renal ischemia–reperfusion injury. Biochem Pharmacol. 2005;69:1121–1131
   PubMed Web of Science ®Google Scholar
• Saikumar P, Venkatachalam MA. Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol. 2003;23:511–521
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Tomita N, Yoshimura S, et al. Hypoxia-induced renal epithelial cell death through caspase-dependent pathway: Role of Bcl-2, Bcl-xL and Bax in tubular injury. Int J Mol Med. 2004;14:633–640
   PubMed Web of Science ®Google Scholar
• Daemen MA, van ‘t Veer C, Denecker G, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest. 1999;104:541–549
   PubMed Web of Science ®Google Scholar
• Yang B Jain, S, Ashra SY, Furness PN, Nicholson ML. Apoptosis and caspase-3 in long-term renal ischemia/reperfusion injury in rats and divergent effects of immunosuppressants. Transplantation. 2006;81:1442–1450
   PubMed Web of Science ®Google Scholar
• Yang C, Jia Y, Zhao T, et al. Naked caspase 3 small interfering RNA is effective in cold preservation but not in autotransplantation of porcine kidneys. J Surg Res. 2013;181:342–354
   PubMed Web of Science ®Google Scholar
• Wang C, Youle RJ. The role of mitochondria in apoptosis. Annu Rev Genet. 2009;43:95–118
   PubMed Web of Science ®Google Scholar
• Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132–1136
   PubMed Web of Science ®Google Scholar
• Brooks C, Wei Q, Cho SG, Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest. 2009;119:1275–1285
   PubMed Web of Science ®Google Scholar